• Menu
  • Menu
  • World
  • World
  • UAE
  • Opinion
  • Subscribe now
    Digital subscription Print subscription ePaper subscription
  • Logout
Digital subscription
Print subscription
ePaper subscription
Trending
UAE holidays 2023 Golf in UAE Corporate Tax Hong Kong Fintech
  • Latest News
  • UAE
    • People
    • Science
    • Government
    • Education
    • Crime
    • Emergencies
    • Environment
    • Health
      • Why Worry
    • Transport
    • Weather
  • Living In UAE
    • Visa+Immigration
    • Housing
    • Phone+Internet
    • Banking
    • Transport
    • Health
    • Education
    • Relocate
    • Reader Queries
    • Safety+Security
  • Business
    • Banking & Insurance
    • Aviation
    • Property
    • Tax News
    • Corporate Tax
    • Analysis
    • Travel & Tourism
    • Markets
    • Retail
    • Corporate News
    • Tech
    • Auto
  • Best Buys
    • Electronics
    • Home and Kitchen
    • Offers
    • Consumables
    • Lifestyle
  • Your Money
    • Saving and Investment
    • Budget Living
    • Taxation
    • Expert Columns
    • Community Tips
    • Cryptocurrency
  • Food
    • Cooking and Cuisines
    • Guide to Cooking
    • Videos
  • Friday
    • Beauty
    • Wellbeing
    • Art & People
    • Home
    • Friday Partner
  • Games
    • Daily Crossword
    • Sudoku
    • Word Search
    • Spell It
    • Play
  • Parenting
    • Pregnancy & Baby
    • Learning & Play
    • Child Health
    • For Mums & Dads
    • Ask Us
    • Games
  • World
    • Gulf
      • Bahrain
      • Kuwait
      • Oman
      • Qatar
      • Saudi
      • Yemen
    • Mena
    • Europe
    • Africa
    • Americas
    • Asia
      • India
      • Pakistan
      • Philippines
    • Australia-New Zealand
    • Corrections
  • Opinion
    • Columnists
    • Editorials
    • Letters
    • From the Editors
  • Special Reports
  • UAE Success Stories
  • Magical Dubai
    • Dubai Life
    • Live the Luxury
    • Culture and History
    • Adventure
    • Staying Connected
  • Photos
    • News
    • Entertainment
    • Lifestyle
    • Business
    • Sports
  • Sport
    • UAE Sport
    • Cricket
      • IPL
        • Chennai
        • Delhi
        • Punjab
        • Kolkata
        • Mumbai
        • Rajasthan
        • Bangalore
        • Hyderabad
        • Gujarat
        • Lucknow
        • Live Scores
        • Point Table
        • Top Scorers
      • ICC
      • T20 World Cup 2022
    • Motorsport
    • Football
    • Tennis
    • Golf in UAE
      • UAE
      • World
      • Photos & Videos
      • Course Reviews
      • Learn to Play
      • Gear
  • Entertainment
    • Hollywood
    • Bollywood
    • South Indian
    • Arab Celebs
    • Music
    • OTT
  • Going Out
  • Auto
  • Lifestyle
    • Health+Fitness
    • Community
    • Fashion
  • GN Reach
  • Jobs
  • Tech
    • Electronics
    • Gaming
    • Media
  • Videos
    • How-To
    • Best Of Bollywood
    • News
    • Entertainment
    • Business
    • Sport
    • Community
    • Technology
  • GN Focus
    • Special Features
  • 50 MENA Leaders
  • The Kurator
    • Life
    • Luxury
    • Style
  • Gold-Forex
  • Gratuity Calculator
  • Notifications
  • Gold/Forex
  • Prayer Times
  • Cinema Listing
  • GN Store
  • About Gulf News
  • Contact us
  • Work with us
  • Terms and Conditions
  • Privacy Policy
  • Advertise with us
  • Reach by GN
  • GN Focus
  • Gulf News epaper
  • Sitemap
  • Have your say
  • Printing Services
  • © Al Nisr Publishing LLC 2023. All rights reserved.
    COVID vaccines approved for emergency use, for front-liners

    World

    Login / Sign Up
    Logout
    Friday, June 9, 2023
    Gold / Forex

    World

    • Gulf
    • Mena
    • Europe
    • Africa
    • Americas
    • Asia
    • Australia-New Zealand
    • Corrections
    All Sections

    COVID vaccines approved for emergency use, for front-liners

    Advances in the global race for an effective, safe COVID-19 shot


    Published:  September 16, 2020 18:20 Jay Hilotin, Senior Assistant Editor

    1 of 10
    20200811 sputnik v
    1. SPUTNIK V: Approved on August 11, 2020. The Russian health ministry registered the first vaccine against COVID-19, named Sputnik V. The vaccine was developed by the Russian biotech company Gamaleya. Sputnik V is currently on clinical trials in a number of countries. Last week, the Russian Health Ministry announced that the first batch of Sputnik V vaccine against COVID-19 has been released into "civil circulation". No price has been published yet for the Sputnik V. Image Credit: AP
    2 of 10
    Cansino Ad5-nCoV vaccine
    2. AD5-NCOV: Approved on June 25, 2020. Cansino Biologics' Ad5-nCoV vaccine was approved by the Central Military Commission of the People's Liberation Army. Based on adenovirus type 5, the vaccine was developed jointly by CanSino and China's military research unit. The shot showed promise following the end of Phase 2 trials. On August 10, 2020, CanSino has announced it was set to launch a Phase III trial of Ad5-nCOV in Saudi Arabia. No price has been published for the shot yet. Image Credit: File
    3 of 10
    20200907 sinovac
    3. SINOVAC: Approved in June. SinoVac Biotech's coronavirus vaccine in a front-runner among the WHO-listed candidate vaccines. On August 28, 2020 (Friday) Chinese state media Xinhua reported that two vaccine candidates in China were approved in June for the emergency-use programme were launched in July. Reuters also reported that Sinovac Biotech's coronavirus vaccine candidate had been approved for "emergency use" in China. On September 7, 2020, China displayed its homegrown coronavirus vaccines for the first time at the China International Fair for Trade in Services (CIFTIS) in Beijing. Image Credit: AFP
    4 of 10
    NAT FILE UAE VACCINE TRIAL-1600154842538
    4. SINOPHARM: Approved on September 14, 2020. The UAE announced the approval of a vaccine for front-line workers. The UAE has hosted the world's first Phase III clinical trials for an inactivated vaccine. The six-week Abu Dhabi trial was conducted on 31,000 volunteers from 125 different nationalities. The vaccine was developed by Sinopharm CNBG. Clinical data show that the vaccine is both safe and effective and triggers strong immune response, generating antibodies to the virus, according to Abdul Rahman Al Owais, Minister of Health and Prevention. The vaccine was also administered successfully on 1,000 volunteers with chronic diseases. Photo shows Dr Jamal Al Kaabi, acting undersecretary, Department of Health, Abu Dhabi, taking part in the Abu Dhabi trial. Image Credit:
    5 of 10
    Clinical trials
    Following are leading vaccine candidates undergoing final clinical trials. Image Credit: Gulf News
    6 of 10
    Pfizer vaccine BNT162b2
    FRONT-RUNNER: On September 16, 2020 (Wednesday), Pfizer Inc. said its vaccine trial showed promising safety signs after more than 12,000 people received their second of two doses. Pfizer is in the final stages of Phase 3 trials for its coronavirus vaccines developed jointly with Germany's BioNTech. As of September 7, 2020, Pfizer-BioNTech had already enrolled 25,189 patients in the phase 2/3 clinical trial for its BNT162b2 shot. Image Credit: Reuters
    7 of 10
    Covaxine Bharat Biotect
    BHARAT BIOTECH: On September 15, 2020, Indian health regulators said Covaxin, developed by India’s Bharat Biotech, is on track with its Covaxin clinical trial. Bharat Biotech is one of the two locally developed vaccines undergoing tests. Both Zydus Cadila and Bharat Biotech have completed Phase-I trials. Results are being analysed. They have started recruitment for Phase II studies. Image Credit: Twitter
    8 of 10
    OPN_Moderna-Vaccine
    mRNA-1273: On July 26, 2020, Moderna kicked off the phase 3 clinical trial of its coronavirus vaccine in multiple sites, mostly in the US. The trial seeks to enroll a diverse population (27% non-White Americans), out of the target of 30,000 subjects. Volunteers enrolled early in the study are starting to contribute to the efficacy readout now. Participants currently being enrolled will get their booster shot after four weeks and will start contributing to the efficacy readout (whether or not they get COVID-19) two weeks after that. Image Credit: AP
    9 of 10
    Serum Institute Pune India vaccine
    SERUM INSTITUTE: On September 15, 2020 (Tuesday), Indian Council of Medical Research (ICMR) director general Dr Balram Bhargava said that Serum Institute of India (SII) has completed Phase II-B3 trials. The pharma company will start Phase-III trial at 14 locations after clearances. Image Credit: NYT
    10 of 10
    OPN 200916 BUSINESS VACCINE
    WHO LIST: The world desperately needs a vaccine to end the COVID-19 pandemic. According to September 9, 2020 "landscape" list published by the World Health Organisation (WHO), there are currently at least 12 vaccine candidates undergoing Phase 3 trials. The platforms used by the frontrunners include (a) inactivated, (b) messenger RNA, (c) Adenovirus, (d) DNA, and (e) protein sub-unit. Image Credit: AP

    Trending

    • Philippines: Two public holidays coming up this June

      Philippines: Two public holidays coming up this June


    • Kuwait deports 680 expats in three days

      Kuwait deports 680 expats in three days


    • Kuwait announces 6-day Eid holiday for public sector

      Kuwait announces 6-day Eid holiday for public sector


    • Visa-free travel for eligible Filipinos to Canada
      Update

      Visa-free travel for eligible Filipinos to Canada


    • Philippine court denies bail for Duterte critic: Lawyer

      Philippine court denies bail for Duterte critic: Lawyer


    • India set to host 71st Miss World 2023

      India set to host 71st Miss World 2023

    Latest In

    • Watch Nidhi Razdan: BJP has a Congress problem

      18 minutes ago

    • Saeed and AlDhabi share a love for the written word

      20 minutes ago

    • Burjeel to set up neuroscience institute in Abu Dhabi

      28 minutes ago

    • Hive Show is at Expo Centre Sharjah from 14-16 June

      39 minutes ago

    • In Dubai, business optimism at 3-year high, jobs up too

      1 hour ago

    Go back to top
    Network links:
    • getthat
    • Jobs
    • GN Store
    • About Gulf News
    • Contact us
    • Work with us
    • Terms and Conditions
    • Privacy Policy
    • Advertise with us
    • Reach by GN
    • GN Focus
    • Gulf News epaper
    • Sitemap
    • Have your say
    • Printing Services
    Find us on Social
    © Al Nisr Publishing LLC 2023. All rights reserved.
    This website stores cookies on your computer. These cookies are used to improve your experience and provide more personalized service to you. Both on your website and other media. To find out more about the cookies and data we use, please check out our Privacy Policy.
    Share on Facebook
    Share on Twitter
    Share on Whatsapp
    Share on Mail
    Share on LinkedIn
    Close
    Gulf News

    Get Breaking News Alerts From Gulf News

    We’ll send you latest news updates through the day. You can manage them any time by clicking on the notification icon.

    Subscribe No Thanks
    Continue reading Gulf News
    Dear Reader, please register to read gulfnews.com

    Dear Reader,

    This section is about Living in UAE and essential information you cannot live without.

    Register to read and get full access to gulfnews.com

    Create your account
    or login if you already have one
    First name is required.
    Last name is required.
    Please enter a valid email address.
    Password should have minimum 7 characters with at least one letter and number
    Passwords do not match

    By clicking below to sign up, you're agreeing to our Terms of Use and Privacy Policy

    Login your account
    New to Gulf News? Sign up now
    Please enter your email address.
    Please enter your password.

    Forgot password

    or